Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuharu Ueda

Showing results (71-80 of 381) with videos related to

Pageof 39
Sort By:
JACC. Case Reports|July 28, 2021
Early Progression of Aortic Stenosis Associated With Iatrogenic Variant Transthyretin Amyloidosis After Domino Liver TransplantationYasuhito Hosoda, Mitsuharu Ueda, Jun Takaki, et al.
British Journal of Haematology|May 7, 2022
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myelomaYawara Kawano, Hiroyuki Hata, Seiji Takashio, et al.
Orphanet Journal of Rare Diseases|May 23, 2019
Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithmYoshiki Sekijima, Mitsuharu Ueda, Haruki Koike, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2012
Interaction between amyloid fibril formation and extracellular matrix in the proceedings of VIIIth International Symposium on Familial Amyloidotic PolyneuropathyYohei Misumi, Mitsuharu Ueda, Konen Obayashi, et al.
Orphanet Journal of Rare Diseases|January 19, 2018
Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithmYoshiki Sekijima, Mitsuharu Ueda, Haruki Koike, et al.
Rinsho Shinkeigaku = Clinical Neurology|October 26, 2022
[Dystrophia myotonica Type 1 associated with glioblastoma: a case report]Takashi Katayama, Jun-Ichiro Kuroda, Kazutaka Ohta, et al.
Nephron. Clinical Practice|July 2, 2005
Role of extracellular superoxide dismutase in patients under maintenance hemodialysisMasaaki Nakamura, Yukio Ando, Keiko Sasada, et al.
Brain Research|February 12, 2023
Brain structural changes in patients with chronic methylmercury poisoning in MinamataToshinori Hirai, Osamu Abe, Masaaki Nakamura, et al.
Cellular and Molecular Life Sciences : CMLS|August 2, 2022
α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formationYasuteru Inoue, Masayoshi Tasaki, Teruaki Masuda, et al.
Journal of the Neurological Sciences|May 1, 2020
Monitoring of asymptomatic family members at risk of hereditary transthyretin amyloidosis for early intervention with disease-modifying therapiesMitsuharu Ueda, Yoshiki Sekijima, Haruki Koike, et al.
Pageof 39

Showing results (71-80 of 381) with videos related to

Sort By:
Pageof 39
JACC. Case Reports|July 28, 2021
Early Progression of Aortic Stenosis Associated With Iatrogenic Variant Transthyretin Amyloidosis After Domino Liver TransplantationYasuhito Hosoda, Mitsuharu Ueda, Jun Takaki, et al.
British Journal of Haematology|May 7, 2022
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myelomaYawara Kawano, Hiroyuki Hata, Seiji Takashio, et al.
Orphanet Journal of Rare Diseases|May 23, 2019
Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithmYoshiki Sekijima, Mitsuharu Ueda, Haruki Koike, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2012
Interaction between amyloid fibril formation and extracellular matrix in the proceedings of VIIIth International Symposium on Familial Amyloidotic PolyneuropathyYohei Misumi, Mitsuharu Ueda, Konen Obayashi, et al.
Orphanet Journal of Rare Diseases|January 19, 2018
Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithmYoshiki Sekijima, Mitsuharu Ueda, Haruki Koike, et al.
Rinsho Shinkeigaku = Clinical Neurology|October 26, 2022
[Dystrophia myotonica Type 1 associated with glioblastoma: a case report]Takashi Katayama, Jun-Ichiro Kuroda, Kazutaka Ohta, et al.
Nephron. Clinical Practice|July 2, 2005
Role of extracellular superoxide dismutase in patients under maintenance hemodialysisMasaaki Nakamura, Yukio Ando, Keiko Sasada, et al.
Brain Research|February 12, 2023
Brain structural changes in patients with chronic methylmercury poisoning in MinamataToshinori Hirai, Osamu Abe, Masaaki Nakamura, et al.
Cellular and Molecular Life Sciences : CMLS|August 2, 2022
α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formationYasuteru Inoue, Masayoshi Tasaki, Teruaki Masuda, et al.
Journal of the Neurological Sciences|May 1, 2020
Monitoring of asymptomatic family members at risk of hereditary transthyretin amyloidosis for early intervention with disease-modifying therapiesMitsuharu Ueda, Yoshiki Sekijima, Haruki Koike, et al.
Pageof 39